Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance

Ryan J. Atkins, Stanley S. Stylli, Natalie Kurganovs, Stefano Mangiola, Cameron J. Nowell, Thomas M. Ware, Niall M. Corcoran, Daniel V. Brown, Andrew H. Kaye, Andrew Morokoff, Rodney B. Luwor, Christopher M. Hovens, Theo Mantamadiotis

Research output: Contribution to journalArticleResearchpeer-review

25 Citations (Scopus)


Glioblastoma (GBM) tumor cells exhibit drug resistance and are highly infiltrative. GBM stem cells (GSCs), which have low proliferative capacity are thought to be one of the sources of resistant cells which result in relapse/recurrence. However, the molecular mechanisms regulating quiescent-specific tumor cell biology are not well understood. Using human GBM cell lines and patient-derived GBM cells, Oregon Green dye retention was used to identify and isolate the slow-cycling, quiescent-like cell subpopulation from the more proliferative cells in culture. Sensitivity of cell subpopulations to temozolomide and radiation, as well as the migration and invasive potential were measured. Differential expression analysis following RNAseq identified genes enriched in the quiescent cell subpopulation. Orthotopic transplantation of cells into mice was used to compare the in vivo malignancy and invasive capacity of the cells. Proliferative quiescence correlated with better TMZ resistance and enhanced cell invasion, in vitro and in vivo. RNAseq expression analysis identified genes involved in the regulation cell invasion/migration and a three-gene signature, TGFBI, IGFBP3, CHI3L1, overexpressed in quiescent cells which correlates with poor GBM patient survival.

Original languageEnglish
Pages (from-to)353-364
Number of pages12
JournalExperimental Cell Research
Issue number2
Publication statusPublished - 15 Jan 2019


  • Cancer stem cells
  • GBM
  • Gene expression
  • Glioblastoma
  • Invasion
  • Migration
  • Oregon green
  • Proliferation
  • Quiescence
  • Resistance

Cite this